Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | PSMB5 | P28074 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MPI | P34949 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CCR1 | P32246 | 1/20 | 0.33 |
| ▸ | CCR5 | P51681 | 1/20 | 0.33 |
| ▸ | CCR8 | P51685 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14599170 | 0.77 | LMNA (0.37) | CYP1A2CYP2A6ALDH1A1MAPTKDM4E | |
| SCHEMBL18630341 | 0.77 | ALDH1A1 (0.32) | CYP1A2CYP2A6ALDH1A1CCR1CCR5 | |
| SCHEMBL14493595 | 0.77 | CYP3A4 (0.39) | ALDH1A1MAPTKDM4EMEN1KMT2A | |
| SCHEMBL30399331 | 0.77 | NQO2 (0.36) | ALDH1A1MAPTLMNA | |
| SCHEMBL18630364 | 0.77 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL6844953 | 0.73 | CYP1A2 (0.43) | CYP1A2CYP2A6ALDH1A1PSMB5MAPT | |
| SCHEMBL14493608 | 0.73 | CYP11B1 (0.36) | CYP2A6ALDH1A1KDM4ENOS3NOS1 | |
| SCHEMBL14599176 | 0.71 | ALDH1A1 (0.34) | CYP1A2ALDH1A1MAPTKDM4ESMN1; SMN2 | |
| SCHEMBL3701838 | 0.71 | CYP1A2 (0.52) | CYP1A2CYP2A6ALDH1A1PSMB5MAPT | |
| SCHEMBL8404559 | 0.71 | CYP1A2 (0.52) | CYP1A2CYP2A6ALDH1A1MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10249830-B2 | Carbazole-based compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-04-02 | — | — | US | disclosed |
| US-20170077419-A1 | CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-03-16 | — | — | US | disclosed |
| US-9527828-B2 | Method for expanding hematopoietic stem cells using heterocyclic compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-12-27 | — | — | US | disclosed |
| US-9527828-B2 | Method for expanding hematopoietic stem cells using heterocyclic compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-12-27 | — | — | US | disclosed |
| EP-2218716-B1 | METHOD FOR AMPLIFYING HEMATOPOIETIC STEM CELLS USING HETEROCYCLIC COMPOUND | NISSAN CHEMICAL IND LTD (JP) | 2016-11-16 | — | — | EP | disclosed |
| US-9328085-B2 | Heterocyclic compounds and expansion agents for hematopoietic stem cells | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-05-03 | — | — | US | disclosed |
| US-9328085-B2 | Heterocyclic compounds and expansion agents for hematopoietic stem cells | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-05-03 | — | — | US | disclosed |
| US-20140227780-A1 | METHOD FOR PRODUCING MEGAKARYOCYTES AND/OR PLATELETS FROM PLURIPOTENT STEM CELLS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-08-14 | — | — | US | disclosed |
| US-20140227780-A1 | METHOD FOR PRODUCING MEGAKARYOCYTES AND/OR PLATELETS FROM PLURIPOTENT STEM CELLS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-08-14 | — | — | US | disclosed |
| EP-2765187-A1 | METHOD FOR PRODUCING MEGAKARYOCYTES AND/OR PLATELETS FROM PLURIPOTENT STEM CELLS | Nissan Chemical Industries, Ltd. (JP) | 2014-08-13 | — | — | EP | disclosed |
| EP-1079271-A1 | Thermally processed image forming material | FUJI PHOTO FILM CO., LTD. (JP) | 2001-02-28 | — | — | EP | disclosed |
| US-6156491-A | Heat developable light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 2000-12-05 | — | — | US | disclosed |
| US-6150084-A | NUCLEATING AGENT AND DIPHOSPHORUS PENTOXIDE-DERIVED COMPOUND; ANTIFOGGING AGENT, CONTRAST | FUJI PHOTO FILM CO., LTD. (JP) | 2000-11-21 | — | — | US | disclosed |
| EP-1045284-A1 | Heat developing method for heat developable image recording material | FUJI PHOTO FILM CO., LTD. (JP) | 2000-10-18 | — | — | EP | disclosed |
| EP-1041433-A1 | Heat-developable photosensitive material and method for forming image using the same | FUJI PHOTO FILM CO., LTD. (JP) | 2000-10-04 | — | — | EP | disclosed |
| EP-1041435-A1 | Heat-developable photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 2000-10-04 | — | — | EP | disclosed |
| EP-1041434-A1 | Heat-developable photosensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 2000-10-04 | — | — | EP | disclosed |
| US-6100022-A | COMPRISES A NONPHOTOSENSITIVE ORGANIC SILVER SALT, A PHOTOSENSITIVE SILVER HALIDE AND A POLYMERIC BINDER HAVING GLASS TRANSITION TEMPERATURE OF-30 TO 40 DEGREE C. ON A SUPPORT, AND IMAGE FORMING LAYER CONTAINING NUCLEATING AGENT | FUJI PHOTO FILM CO., LTD. (JP) | 2000-08-08 | — | — | US | disclosed |
| EP-1020760-A2 | Heat developable image recording material | FUJI PHOTO FILM CO., LTD. (JP) | 2000-07-19 | — | — | EP | disclosed |
| EP-0990946-A1 | Heat-developable photosensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 2000-04-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10249830-B2 | Carbazole-based compound and organic light-emitting device including the same | OCIAD1, OXA1L, OCIAD2 | CYP1A2 42/4885CYP2A6 923/4885ALDH1A1 229/4885 |
| US-20170077419-A1 | CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | OCIAD1, OXA1L, CYP1A1 | CYP1A2 42/4885CYP2A6 786/4885ALDH1A1 202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.